|
Market Cap (4-Jul) $281,673,600 (480th) |
Close (30-Jun) $3.40 |
Volume (30-Jun) 0 |
Shortsold (6-Aug) 667 (0.00%) (670th) |
|
52w High $3.12 |
52w Low $2.13 |
P/E 22.47 |
EPS 0.1 |
AFP released this announcement to the ASX on 28 April 2021, 7:30. The announcement is marked as price sensitive, and is 4 page(s) in length and 148.85kb in size.
You can view all announcements from AFP and see how they appear on a price chart on the announcements page.
At the date of this announcement, AFP was 0.001% short sold according to ASIC data. It was ranked the 650th most shorted stock on the ASX. It remains ranked 670th as of the latest reported data (06 August 2021).
| Other Recent Announcements from AFP | |
|---|---|
| Notice of Annual Meeting of Shareholders 2023 | 30 June 2023, 7:30 |
| Dividend/Distribution - AFP | 30 May 2023, 14:13 |
| Annual Meeting and Closing Date for Director Nominations | 26 May 2023, 14:58 |
| AFT licenses Maxigesic IV in the US | 28 April 2021, 7:30 |
| Crystawash Extend distribution in UAE, Kuwait, Oman and Ken | 12 April 2021, 8:52 |
| AFT secures new partners in Poland and Greece | 7 April 2021, 7:30 |
| AFT updates earnings guidance | 1 April 2021, 7:30 |
You must be logged in to post a reply.
AFT Pharmaceuticals 